Mr. Mike Seckler reports

EVOME MEDICAL TECHNOLOGIES BOLSTERS BOARD OF DIRECTORS WITH APPOINTMENT OF STRATEGIC SENIOR HEALTHCARE EXECUTIVES WAYNE ANDERSON AND BILL GARBARINI, APPOINTS KENNETH KASHKIN, MD, AS CHAIRMAN

Evome Medical Technologies Inc. has appointed two senior health care executives to its board of directors.

Wayne Anderson, former president and chief executive officer of Ferring Pharmaceuticals USA, has joined as a non-executive member of the board of directors.

Bill Garbarini, a former Ferring Pharmaceuticals USA executive and current chief operating officer of Conceivable Life Sciences, a venture-backed in-vitro fertilization company, will also join as a non-executive member of the board of directors.

In addition, Kenneth Kashkin, MD, has been appointed chairman of the board of directors. Dr. Kashkin is board certified in internal medicine, neurology and psychiatry with training at, and serving on, the faculties of the University of California, Los Angeles (UCLA) and Yale University Schools of Medicine. He has led development at divisions of Bayer, Abbott, Knoll/BASF Pharma and Baxter.

"Now that we have successfully executed on our turnaround plan, I am pleased to have Wayne and Bill join the board," said Mike Seckler, chief executive officer of Evome. "I worked with both of these talented and successful health care executives for many years while at Ferring and I am eager to benefit from their valuable guidance and expertise, particularly in the realms of product launch and commercialization. Dr. Kashkin's contributions will play a crucial role in advancing our innovation and development strategies, aligning with our vision to democratize our Biodex Brands. I can now say we have completed all of the necessary steps to transform our company. We have driven revenue growth, developed new products, cut costs and restructured our debt. The final step was to add some seasoned talent to our board to assist us in driving shareholder value."